Loading…
avatar for Jerry Keybl, Ph.D.

Jerry Keybl, Ph.D.

MilliporeSigma
Head of Cell and Gene Therapy Manufacturing
Jerry Keybl heads the Cell & Gene Therapy Manufacturing business for MilliporeSigma. As part of a diverse science and technology company, Jerry is focused on products and services for cell therapy and viral vector manufacturing, with the potential to transform therapies to cures. Jerry joined MilliporeSigma in 2016 and drove the first integrated strategy for the newly combined company (EMD Millipore and Sigma Aldrich), before joining the leadership team of the Gene Editing and Novel Modalities business. In this role he spearheaded the acquisition of FloDesign Sonics and the company’s large scale viral vector CDMO expansion in Carlsbad, California. 
 
Prior to joining MilliporeSigma, Jerry worked for the Boston Consulting Group as a Project Leader. Jerry holds a Ph.D. in Chemical Engineering from MIT, and two bachelor’s degrees from the University of Pennsylvania: a B.S. (engineering) in chemical and biomolecular engineering and a B.S. (economics) from the Wharton School.  
 
MilliporeSigma is the Life Science business of Merck KGaA, Darmstadt, Germany. 
  • Timezone
  • Filter By Type
  • Executive Interview
  • Keynote
  • Networking Break
  • Panel Session
  • Virtual Happy Hour